Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 16, Number 11—November 2010

Research

Lymphotropism of Merkel Cell Polyomavirus Infection, Nova Scotia, Canada

Sonia Toracchio, Annette Foyle, Vojtech Sroller1, Jon A. Reed, Jun Wu, Claudia A. Kozinetz, and Janet S. ButelComments to Author 
Author affiliations: Baylor College of Medicine, Houston, Texas, USA (S. Toracchio, V. Sroller, J.A. Reed, C.A. Kozinez, J.S. Butel); Dalhousie University, Halifax, Nova Scotia, Canada (A. Foyle); Queen Elizabeth II Health Science Center, Halifax (A. Foyle); and Public Health Agency of Canada, Ottawa, Ontario, Canada (J. Wu); 1Current affiliation: Institute of Hematology and Blood Transfusion, Prague, Czech Republic

Main Article

Table 1

MCPyV DNA from lymphoid and nonlymphoid samples, Halifax, Nova Scotia, Canada, and from MCC tissues, Houston, Texas, USA, 1994–2008*

Type of specimen No. samples tested No. (%) MCPyV positive
Frozen samples from Halifax, Nova Scotia, Canada
Malignant lymphomas 196 13 (6.6)
Benign lymph nodes 110 11 (10.0)
Lymph nodes with non-MCC metastatic
 cancer 27 0
Other inflammatory tissues 7 0
Other neoplastic non-MCC tissues 13 0
Totals
353
24 (6.8)
Fixed tissues from Houston, Texas, USA
MCC 4 2 (50.0)
Melanoma 4 0

*MCPyV, Merkel cell polyomavirus; MCC, Merkel cell carcinoma.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO